Florida / New York
Ph: 561.316.3330
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Exxe Group reported among other elements, the MMeditech acquisition brings immediate revenues to Exxe, a high level of operating profitability, and a backlog of $2.8 million for 2021.
The terms of the transaction were not provided.
The technologies developed by the RCSI Tissue Engineering Research Group have extensive pre-clinical and human data demonstrating their effectiveness in the treatment of both hard and soft tissues.
September 17, 2020 QIAGEN N.V. today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash.
BioNTech notes the transaction is expected to close in the fourth quarter of 2020. The Company plans to be able to produce up to 250 million doses of BNT162b2 in the first half of 2021.
Pennant will continue to pursue opportunities for growth in the home health, hospice and senior living industries, targeting strategic and underperforming operations of all sizes.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330